Banks and telcos kept the ASX green, while NextDC’s power problems wrecked tech and the RBA put another rate hike back on the ...

Pharmacy chain owners Sigma Healthcare and EBOS Group have issued solid trading updates ahead of their respective AGMs ...

From Africa to Western Australia, a group of ASX goldies is ramping up output or advancing projects towards near-term ...

The ASX lost its early spark as NextDC copped a 40% hiding, while Musk cooked up another mega-deal on Wall Street.

Open-label extension trials provide long-term follow-up after a main trial and are an important part of drug development for ASX biotechs.

LinQ Minerals has been a standout performer among ASX juniors this year, as it looks to grow its massive NSW gold and copper ...

CEOs of smaller ASX biotechs are paying the price of trial failures, regulatory setbacks and difficult capital markets in ...

The ASX took a lunchtime beating as banks and miners slumped, with BHP's copper woes and NAB's job cuts adding to the pain.

Nurses, teachers and aged-care workers are among millions caught in a budget trap that lawyers say will force a national will ...

Icetana’s alliance with SoftBank Robotics is taking its AI surveillance software beyond CCTV, connecting incident detection ...

As prediction markets boom, ASX-listed InFocus eyes the action with its first Codexa customer and a conditional US$2.4m deal.

Resources investor Colin Petroulas has lifted his stake in Black Bear as it advances its Texas silver mine restart and Nevada ...